154 related articles for article (PubMed ID: 37133474)
1. Sequential Treatment With Topical Trifarotene and Injectable NASHA Gel in Acne Scars: A Case Series.
Belmontesi M
J Drugs Dermatol; 2023 May; 22(5):502-506. PubMed ID: 37133474
[TBL] [Abstract][Full Text] [Related]
2. An Overview on the Management of Atrophic Acne Scars: The Role of Trifarotene as an Adjunct.
Conte S; Li MK
Skin Therapy Lett; 2024 Jul; 29(4):1-4. PubMed ID: 38963911
[TBL] [Abstract][Full Text] [Related]
3. Improvement of Atrophic Acne Scars in Skin of Color Using Topical Synthetic Epidermal Growth Factor (EGF) Serum: A Pilot Study.
Stoddard MA; Herrmann J; Moy L; Moy R
J Drugs Dermatol; 2017 Apr; 16(4):322-326. PubMed ID: 28403265
[TBL] [Abstract][Full Text] [Related]
4. The Role of Topical Retinoids in Prevention and Treatment of Atrophic Acne Scarring: Understanding the Importance of Early Effective Treatment.
Tan J; Tanghetti E; Baldwin H; Stein Gold L; Lain E
J Drugs Dermatol; 2019 Mar; 18(3):255-260. PubMed ID: 30909329
[TBL] [Abstract][Full Text] [Related]
5. Topical Tazarotene Gel, 0.1%, as a Novel Treatment Approach for Atrophic Postacne Scars: A Randomized Active-Controlled Clinical Trial.
Afra TP; Razmi T M; Narang T; Dogra S; Kumar A
JAMA Facial Plast Surg; 2019 Mar; 21(2):125-132. PubMed ID: 30452511
[TBL] [Abstract][Full Text] [Related]
6. Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentation.
Alexis A; Del Rosso JQ; Forman S; Martorell A; Browning J; Laquer V; Desai SR; York JP; Chavda R; Dhawan S; Moore AY; Stein-Gold L
Int J Dermatol; 2024 Jun; 63(6):806-815. PubMed ID: 38685118
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Chavda R; Kerrouche N; Tan J
Am J Clin Dermatol; 2019 Oct; 20(5):725-732. PubMed ID: 31209851
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Safety of Acne Scar Treatment With Nonanimal Stabilized Hyaluronic Acid Gel.
Dierickx C; Larsson MK; Blomster S
Dermatol Surg; 2018 Nov; 44 Suppl 1():S10-S18. PubMed ID: 30358630
[TBL] [Abstract][Full Text] [Related]
9. Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.
Schleicher S; Moore A; Rafal E; Gagne-Henley A; Johnson SM; Dhawan S; Chavda R; York JP; Sforzolini B; Holcomb K; Ablon G; Del Rosso J; Dreno B
Dermatol Ther (Heidelb); 2023 Dec; 13(12):3085-3096. PubMed ID: 37838987
[TBL] [Abstract][Full Text] [Related]
10. Management of Acne Vulgaris With Trifarotene.
Tan J; Chavda R; Baldwin H; Dreno B
J Cutan Med Surg; 2023; 27(4):368-374. PubMed ID: 36927117
[TBL] [Abstract][Full Text] [Related]
11. Update: Mechanisms of Topical Retinoids in Acne.
Dreno B; Kang S; Leyden J; York J
J Drugs Dermatol; 2022 Jul; 21(7):734-740. PubMed ID: 35816067
[TBL] [Abstract][Full Text] [Related]
12. Investigating the Efficacy of Modified Lipoaspirate Grafting to Improve the Appearance of Atrophic Acne Scars: A Pilot Study.
Vingan NR; Wamsley CE; Panton JA; Mangalagiri D; Turer D; Akgul Y; Barillas J; Culver A; Kenkel JM
Aesthet Surg J; 2023 Jul; 43(8):NP613-NP630. PubMed ID: 37051925
[TBL] [Abstract][Full Text] [Related]
13. Platelet-rich plasma versus CROSS technique with 100% trichloroacetic acid versus combined skin needling and platelet rich plasma in the treatment of atrophic acne scars: a comparative study.
Nofal E; Helmy A; Nofal A; Alakad R; Nasr M
Dermatol Surg; 2014 Aug; 40(8):864-73. PubMed ID: 25006854
[TBL] [Abstract][Full Text] [Related]
14. Improvement in Atrophic Acne Scars Using Topical Synthetic Epidermal Growth Factor (EGF) Serum: A Pilot Study.
Seidel R; Moy RL
J Drugs Dermatol; 2015 Sep; 14(9):1005-10. PubMed ID: 26355620
[TBL] [Abstract][Full Text] [Related]
15. A review of the topical management of acne and its associated sequelae in the Asia-Pacific region with a spotlight on trifarotene.
See JA; Chavda R; Kon KM; Goodman GJ; Oblepias MS; Nadela RE; Oon HH; Aurangabadkar S; Suh DH; Chan HHL; Lahiri K
Int J Dermatol; 2024 Jun; 63(6):704-713. PubMed ID: 38643368
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy using subcision, needling, and platelet-rich plasma in the management of grade 4 atrophic acne scars: A pilot study.
Bhargava S; Kroumpouzos G; Varma K; Kumar U
J Cosmet Dermatol; 2019 Aug; 18(4):1092-1097. PubMed ID: 30924301
[TBL] [Abstract][Full Text] [Related]
17. Advances in Topical Management of Adolescent Facial and Truncal Acne: A Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% Cream.
Eichenfield L; Kwong P; Lee S; Krowchuk D; Arekapudi K; Hebert A
J Drugs Dermatol; 2022 Jun; 21(6):582-586. PubMed ID: 35674762
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of topical timolol 0.5% plus saline 0.9% versus each one alone in acne scar trichloroacetic acid-CROSS therapy: A blinded randomized controlled trial.
Ghassemi M; Shahverdi MH; Behrangi E; Hosseini-Baharanchi FS; Goodarzi A
Dermatol Ther; 2022 Apr; 35(4):e15341. PubMed ID: 35094447
[TBL] [Abstract][Full Text] [Related]
19. Integrated Cooling-Vacuum-Assisted Non-Fractional 1540 nm Erbium:Glass Laser is Effective in Treating Acne Scars.
Politi Y; Levi A; Lapidoth M
J Drugs Dermatol; 2016 Nov; 15(11):1359-1363. PubMed ID: 28095548
[TBL] [Abstract][Full Text] [Related]
20. Prospective Study of Pathogenesis of Atrophic Acne Scars and Role of Macular Erythema.
Tan J; Bourdès V; Bissonnette R; Petit B Eng L; Reynier P; Khammari A; Dreno B
J Drugs Dermatol; 2017 Jun; 16(6):566-572. PubMed ID: 28686774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
